535 related articles for article (PubMed ID: 26441370)
61. [Therapeutic efficacy of macrolide anti-infective agents and other pharmacological actions].
Azuma A
Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):376-85. PubMed ID: 15768605
[No Abstract] [Full Text] [Related]
62. Diffuse panbronchiolitis: A progressive fatal lung disease that is curable with azithromycin, but only if diagnosed!
Weinberger M; Lesser D
Pediatr Pulmonol; 2019 Apr; 54(4):457-462. PubMed ID: 30609307
[TBL] [Abstract][Full Text] [Related]
63. Clinical implications of macrolide therapy in chronic sinopulmonary diseases.
Martinez FJ; Simon RH
Curr Pharm Des; 2004; 10(25):3095-110. PubMed ID: 15544500
[TBL] [Abstract][Full Text] [Related]
64. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
[TBL] [Abstract][Full Text] [Related]
65. Choosing the right macrolide antibiotic. A guide to selection.
Charles L; Segreti J
Drugs; 1997 Mar; 53(3):349-57. PubMed ID: 9074839
[TBL] [Abstract][Full Text] [Related]
66. Deterioration of asthma in a patient with diffuse panbronchiolitis (DPB) after macrolide therapy.
Matsuno O; Ueno K; Hayama Y; Honda H; Yamane H; Saeki Y
J Asthma; 2010 May; 47(4):486-8. PubMed ID: 20528606
[TBL] [Abstract][Full Text] [Related]
67. Controlled trial for long-term low-dose erythromycin after sinus surgery for chronic rhinosinusitis.
Haxel BR; Clemens M; Karaiskaki N; Dippold U; Kettern L; Mann WJ
Laryngoscope; 2015 May; 125(5):1048-55. PubMed ID: 25425539
[TBL] [Abstract][Full Text] [Related]
68. Macrolide antibiotics and bronchiolitis obliterans following lung transplantation.
Crowley S; Egan JJ
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):923-30. PubMed ID: 16307505
[TBL] [Abstract][Full Text] [Related]
69. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
López-Boado YS; Rubin BK
Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
[TBL] [Abstract][Full Text] [Related]
70. Diffuse panbronchiolitis.
Poletti V; Casoni G; Chilosi M; Zompatori M
Eur Respir J; 2006 Oct; 28(4):862-71. PubMed ID: 17012632
[TBL] [Abstract][Full Text] [Related]
71. Effects of long-term clarithromycin treatment on lavage-fluid markers of inflammation in chronic rhinosinusitis.
Cervin A; Wallwork B; Mackay-Sim A; Coman WB; Greiff L
Clin Physiol Funct Imaging; 2009 Apr; 29(2):136-42. PubMed ID: 19076731
[TBL] [Abstract][Full Text] [Related]
72. The value of a feasibility study into long-term macrolide therapy in chronic rhinosinusitis.
Bewick J; Ahmed S; Carrie S; Hopkins C; Sama A; Sunkaraneni V; Woods J; Morris S; Erskine S; Philpott CM
Clin Otolaryngol; 2017 Feb; 42(1):131-138. PubMed ID: 27223120
[TBL] [Abstract][Full Text] [Related]
73. Macrolides for the treatment of chronic sinusitis, asthma, and COPD.
Gotfried MH
Chest; 2004 Feb; 125(2 Suppl):52S-60S; quiz 60S-61S. PubMed ID: 14872001
[TBL] [Abstract][Full Text] [Related]
74. Inhibition of vascular endothelial growth factor by macrolides in cultured fibroblasts from nasal polyps.
Matsune S; Sun D; Ohori J; Nishimoto K; Fukuiwa T; Ushikai M; Kurono Y
Laryngoscope; 2005 Nov; 115(11):1953-6. PubMed ID: 16319604
[TBL] [Abstract][Full Text] [Related]
75. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
Principi N; Esposito S
Drug Saf; 1999 Jan; 20(1):25-41. PubMed ID: 9935275
[TBL] [Abstract][Full Text] [Related]
76. Pharmacotherapy of Chronic Rhinosinusitis with a Focus on Clarithromycin: An Expert Opinion.
Bhargava SK; Peethambaran K
J Assoc Physicians India; 2018 Oct; 66(10):74-79. PubMed ID: 31317714
[TBL] [Abstract][Full Text] [Related]
77. Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults.
Zeng M; Long XB; Cui YH; Liu Z
Am J Rhinol Allergy; 2011; 25(6):e203-7. PubMed ID: 22185725
[TBL] [Abstract][Full Text] [Related]
78. Approaches to the synthesis of immunolides: selective immunomodulatory macrolides for cystic fibrosis.
Fecik RA; Nguyen PL; Venkatraman L
Curr Opin Drug Discov Devel; 2005 Nov; 8(6):741-7. PubMed ID: 16312149
[TBL] [Abstract][Full Text] [Related]
79. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
80. Treatment of chronic rhinosinusitis with low-dose, long-term macrolide antibiotics: an evolving paradigm.
Hatipoglu U; Rubinstein I
Curr Allergy Asthma Rep; 2005 Nov; 5(6):491-4. PubMed ID: 16216175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
